Cancer drug Tagrisso slashes death rate among lung cancer patients, study finds - UPI.com
Once-a-day use of the targeted cancer pill Tagrisso (osimertinib) cut the five-year death rate in half for a subset of patients with early-stage lung cancer, a new clinical trial shows.
www.upi.com